Page 3 - Viatris News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Viatris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Viatris Today - Breaking & Trending Today

Biocon Biologics completes integration of Viatris' biosimilar business in 120 countries

The company said over 10 emerging markets along with Japan, Australia and New Zealand have transitioned in this final phase of the integration of the biosimilars business acquired from Viatris. With the completion of this significant milestone, Biocon Biologics is now a fully integrated ‘lab to market biosimilars company committed to serving millions of patients across the globe. ....

Business News , Breaking News Events , Latest News Updates , Economic Times , Economic Times News App , Daily Market Updates , Live Business , Biocon Biologics , Biosimilar Business , Emerging Markets , Growing Needs Of Patients , Commercial Footprint , Healthcare System ,

Biocon Biologics Successfully Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe

Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. Biocon Biologics personnel working at the insulin devices manufacturing facility in Bengaluru, India. BENGALURU, India, Nov. 30, 2023 (GLOBE NEWSWIRE) Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the integration of the Viatris’ biosimilars business in 31 European countries has been successfully completed. Following the acquisitio ....

United Kingdom , Czech Republic , United States , Stephanie Wasco , Biocon Biologics , Saurabh Paliwal , Shreehas Tambe , Seema Ahuja , Biocon Biologics Ltd , Un Sustainable Development Goals Sdgs , Biocon Ltd , Biocon Biologics Ltd In Europe , Head Of Communications , Biologics Ltd , North America , Insulin Aspart , Insulin Glargine , Commercial Europe , Biocon Biologics Limited , Development Goals , Generic Formulations , Looking Statements , Neither Biocon , More Information , Corporate Brand , Emerging Markets ,